Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
AUROPHARMA
AUROPHARMA

Aurobindo Pharma Ltd.

NSE: AUROPHARMA
BSE: 524804
Sector: Healthcare
Industry: Pharmaceuticals
1,557.40-25.6 (-1.62%)
8 Jul, 12:00 AM

Stock Scores

Quality Score

89.8 / 100

Value Score

60.6 / 100

Price Momentum Score

95.3 / 100

QVM Score

98.3 / 100

Key Metrics

Market Cap
89609.40
P/E (TTM)
25.57
P/B
2.36
P/S (TTM)
2.66
EV/EBITDA
12.68
CAPE (5Y)
30.85
ROE (TTM)
9.94
ROCE (TTM)
11.69
ROA (TTM)
6.47
Avg 3Y ROE
10.76
Earnings 3Y CAGR
22.41
Sales 3Y CAGR
10.63
Sales 5Y CAGR
6.32
Debt/Equity
0.21
Consensus TP
1620.00
Strong Buy %
29.63
Promoter Holding
51.82
Pledged %
23.65

Share Price

Track Aurobindo Pharma Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: 0.31 %
Low
1,544.1
High
1,636.8
1 Month returns: 7.70 %
Low
1,391.0
High
1,636.8
1 Year returns: 35.70 %
Low
1,016.1
High
1,636.8
3 Year CAGR: 27.56 %
Low
720.5
High
1,636.8
5 Year CAGR: 10.38 %
Low
397.2
High
1,636.8
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Aurobindo Pharma Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Aurobindo Pharma Ltd. Shareholding Pattern

Quarterly breakdown of Aurobindo Pharma Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Aurobindo Pharma Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Aurobindo Pharma Ltd.?
The current share price of Aurobindo Pharma Ltd. is ₹ 1,557.40 as of 8 Jul 2026.
What is the market capitalisation of Aurobindo Pharma Ltd.?
The market capitalisation of Aurobindo Pharma Ltd. stands at ₹ 89,609.40 Cr.
What is the PE ratio of Aurobindo Pharma Ltd.?
The Price-to-Earnings (PE) ratio of Aurobindo Pharma Ltd. is 25.57 as of the latest trailing twelve months data.
What is the ROE and ROCE of Aurobindo Pharma Ltd.?
Aurobindo Pharma Ltd. has a Return on Equity (ROE) of 9.94% and a Return on Capital Employed (ROCE) of 11.69% as per the latest financial reports.
What is the 52-week high and low of Aurobindo Pharma Ltd.?
The 52-week high of Aurobindo Pharma Ltd. is - and the 52-week low is -.
What is the dividend yield of Aurobindo Pharma Ltd.?
The dividend yield of Aurobindo Pharma Ltd. is 0.26% based on the current market price.
What is the FII and DII holding in Aurobindo Pharma Ltd.?
Foreign Institutional Investors (FII) hold 15.24%, Domestic Institutional Investors (DII) hold 22.79% and retail/public investors hold 6.50% of Aurobindo Pharma Ltd. shares.
What sector does Aurobindo Pharma Ltd. belong to?
Aurobindo Pharma Ltd. operates in the Healthcare sector. 66.67% of analysts have a Buy or Strong Buy rating on Aurobindo Pharma Ltd. with a consensus target price of ₹ 1,620.00, implying 4.02% upside from current levels.
What is the beta of Aurobindo Pharma Ltd.?
The beta of Aurobindo Pharma Ltd. is 0.45, indicating its price volatility relative to the broader market. Over the past 1 year, Aurobindo Pharma Ltd. has delivered an absolute return of 37.24%.
What is the RSI of Aurobindo Pharma Ltd.?
The 14-day Relative Strength Index (RSI) of Aurobindo Pharma Ltd. is 57.34, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.